Frontiers in Immunology (Jun 2022)

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer

  • Fangdie Ye,
  • Fangdie Ye,
  • Yingchun Liang,
  • Yingchun Liang,
  • Zhang Cheng,
  • Zhang Cheng,
  • Yufei Liu,
  • Yufei Liu,
  • Jimeng Hu,
  • Jimeng Hu,
  • Weijian Li,
  • Weijian Li,
  • Xinan Chen,
  • Xinan Chen,
  • Jiahao Gao,
  • Haowen Jiang,
  • Haowen Jiang,
  • Haowen Jiang

DOI
https://doi.org/10.3389/fimmu.2022.911902
Journal volume & issue
Vol. 13

Abstract

Read online

Several studies have found that pathological imbalance of alterative splicing (AS) events is associated with cancer susceptibility. carcinogenicity. Nevertheless, the relationship between heritable variation in AS events and carcinogenicity has not been extensively explored. Here, we downloaded AS event signatures, transcriptome profiles, and matched clinical information from The Cancer Genome Atlas (TCGA) database, identified the prognostic AS-related events via conducting the univariate Cox regression algorism. Subsequently, the prognostic AS-related events were further reduced by the least absolute shrinkage and selection operator (LASSO) logistic regression model, and employed for constructing the risk model. Single-sample (ssGSEA), ESTIMATE, and the CIBERSORT algorithms were conducted to evaluate tumor microenvironment status. CCK8, cell culture scratch, transwell invasion assays and flow cytometry were conducted to confirm the reliability of the model. We found 2751 prognostic-related AS events, and constructed a risk model with seven prognostic-related AS events. Compared with high-risk score patients, the overall survival rate of the patients with low-risk score was remarkably longer. Besides, we further found that risk score was also closely related to alterations in immune cell infiltration and immunotherapeutic molecules, indicating its potential as an observation of immune infiltration and clinical response to immunotherapy. In addition, the downstream target gene (DYM) could be a promising prognostic factor for bladder cancer. Our investigation provided an indispensable reference for ulteriorly exploring the role of AS events in the tumor microenvironment and immunotherapy efficiency, and rendered personalized prognosis monitoring for bladder cancer.

Keywords